查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1726264

全球乳癌诊断市场：市场规模、份额、趋势分析（按类型、产品、应用、最终用途和地区）、细分市场预测（2025-2030 年）

Breast Cancer Diagnostics Market Size, Share & Trends Analysis Report By Product (Platform-based, Instrument-based), By Type (Imaging, Biopsy, Genomic Tests, Blood Tests), By Application, By End-use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 110 Pages | 商品交期: 2-10个工作天内

价格

乳癌诊断市场的成长与趋势：

根据 Grand View Research Inc. 的一项新研究，到 2030 年全球乳癌诊断市场规模预计将达到 84.7 亿美元。

预计从 2025 年到 2030 年，市场复合年增长率将达到 7.64%。这一增长主要是由于老龄人口不断增加，他们面临更多的乳癌风险以及乳癌的早期发现，同时人们对乳癌的认识也不断提高。

3D乳房X光摄影和数位乳房断层合成技术的推出，比 2D乳房X光摄影具有更高的准确度，从而支持了市场的成长。这项先进技术比二维乳房乳房X光摄影多检测出 40.0% 的癌症，从而减少患者回访。预计快速的技术进步是未来几年推动市场发展的主要因素。

公司正在采取策略利用其资源开发新产品并加强其供应链。 2019 年 11 月，Exact Sciences Corporation 宣布收购 Genomic Health，增加了产品系列，预计有助于加强公司的市场地位和服务产品。 2021 年 1 月，Hologic Inc. 宣布已同意以约 2.3 亿美国收购 Biotheranostics。 Biotheranostics 是一家针对乳癌和转移性癌症的商业阶段分子诊断提供者。

随着乳癌预测和伴随诊断测试的不断增加，预计市场将会成长。该领域最近推出的产品包括 Myriad Genetics 的 BRACAnalysis CDx，该产品于 2018 年获得 FDA核准作为乳癌伴随诊断。 2019 年 5 月，QIAGEN 推出了 therascreen PIK3CA RGQ PCR 试剂盒，作为诺华专有 PIQRAY 的伴随诊断，以根据切片检查和液体切片检查指导治疗决策。

2019 年 1 月，FUJIFILM Holdings公司宣布其 ASPIRE Cristalle乳房X光摄影系统将推出断层合成切片检查选项。该技术有望透过提供增强的 3D 影像和数位乳房 X 光检查来帮助医生比以往更有效地检测乳癌。

然而，这些成像方式有其自身的风险因素。这些包括使用大量萤光或钡显影剂，以及在成像和内视镜检查的情况下暴露于辐射，这可能导致多种副作用，包括噁心和腹泻。 CT、MRI 和 X 光的使用以及 PET 中使用放射性示踪剂注射所带来的电离辐射暴露风险可能会限制此类筛检方法的采用。因此，诊断成像的副作用等因素对该市场的公司构成了挑战。

乳癌诊断市场：概述

  • 预计诊断成像将在 2024 年占据最大份额的收入，其中血液学检测预计将以最快的速度增长。
  • 从产品角度来看，由于美国、加拿大和英国等已开发国家政府出台强制 45 岁以上女性接受收益占有率等倡议，乳癌检测和筛检整体增加，预计 2024 年基于设备的产品部门将占据最大的收入美国。
  • 预计基于平台的产品领域将在预测期内呈现最快的成长。这些测试主要用于评估女性化疗和标靶治疗的有效性。
  • 根据应用，诊断和预测部分预计将在 2024 年占据市场主导地位，而由于合作的不断增加以及诊断技术进步的努力，预测部分预计将在预测期内呈现最快的复合年增长率。
  • 由于住院人数增加和乳癌负担增加，医院和诊所部门预计将实现 6.92% 的稳定成长率。
  • 由于 NGS 和 PCR 等基于平台的测试的兴起，预计医疗实验室和诊断中心部门在预测期内将呈现最快的复合年增长率。

目录

第一章 分析方法与范围

第二章执行摘要

第三章 市场驱动因素、趋势与范围

  • 市场联动展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场趋势与展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制分析
  • 商业环境分析
    • PESTEL分析
    • 波特五力分析
  • COVID-19影响分析

第四章 业务类型分析

  • 乳癌诊断市场：按类型分類的趋势分析（2024 年和 2030 年）
  • 影像学诊断
    • 诊断影像市场（2018-2030）
  • 切片检查
    • 切片检查市场（2018-2030）
  • 基因组检测
    • 基因组检测市场（2018-2030）
  • 血液检查
    • 血液检测市场（2018-2030）
  • 其他的
    • 其他市场（2018-2030）

第五章 产品业务分析

  • 乳癌诊断市场：产品特定变化分析（2024 年和 2030 年）
  • 平台化产品
    • 平台型产品市场（2018-2030）
  • 基于设备的产品
    • 设备型产品市场（2018-2030）

第六章 依应用程式进行的业务分析

  • 乳癌诊断市场：应用趋势分析（2024 年和 2030 年）
  • 筛检
    • 筛检市场（2018-2030）
  • 诊断和预测
    • 诊断与预测市场（2018-2030）
  • 预后
    • 预测市场（2018-2030）
  • 研究
    • 研究市场（2018-2030）

第七章 按最终用途分類的业务分析

  • 乳癌诊断市场：最终用途趋势分析（2024-2030）
  • 医院和诊所
    • 医院和诊所市场（2018-2030）
  • 医学实验室/诊断中心
    • 医学实验室和诊断中心市场（2018-2030）
  • 其他的
    • 其他市场（2018-2030）

第八章区域业务分析

  • 市场概况：按地区
  • 北美洲
    • 北美乳癌诊断市场（2018-2030）
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 欧洲乳癌诊断市场（2018-2030）
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 亚太地区乳癌诊断市场（2018-2030）
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 拉丁美洲乳癌诊断市场（2018-2030）
    • 主要国家趋势
    • 法律规范
    • 竞争场景
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 中东和非洲乳癌诊断市场（2018-2030）
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第九章 竞争态势

  • 公司分类
  • 战略地图
    • 收购
    • 商业合作
    • 推出新平台
    • 其他的
  • 公司简介/上市公司
    • Hologic Inc.
    • Genomic Health（Exact Sciences Corporation）
    • BD
    • Danaher
    • Koninklijke Philips NV
    • QIAGEN
    • Thermo Fisher Scientific Inc
    • Myriad Genetics
    • Argon Medical Devices, Inc.
    • F. Hoffmann-La Roche Ltd.
Product Code: GVR-3-68038-694-3

Breast Cancer Diagnostics Market Growth & Trends:

The global breast cancer diagnostics market size is expected to reach USD 8.47 billion by 2030, according to a new study by Grand View Research Inc. The market is expected to expand at a CAGR of 7.64% from 2025 to 2030. The growth is largely attributable to the increasing geriatric population exposed to the risk of breast cancer and early detection coupled with increasing awareness about breast cancer.

The introduction of 3D mammography or digital breast tomosynthesis, which is more accurate than 2D mammography, supports market growth. This advanced technology can detect 40.0% more cancers than 2D mammograms and reduce patient recalls. Rapid technological advancements are a major factor expected to drive the market over the coming years.

Companies are adopting strategies that allow them to use their resources to aid in the development of new products, as well as enhance their supply chain. In November 2019, Exact Sciences Corporation announced the acquisition of Genomic Health, which was expected to help enhance the company's market position and offerings by acquiring its product portfolio. In January 2021, Hologic Inc. announced that it has agreed to acquire Biotheranostics for approximately US$ 230 million. Biotheranostics is a commercial-stage molecular diagnostics provider for breast and metastatic cancers.

The increasing launch of predictive and companion diagnostic tests for breast cancer is expected to boost the market growth. Recent launches in the segment include BRACAnalysis CDx by Myriad Genetics, which received FDA approval in 2018 as breast cancer companion diagnostics. In May 2019, QIAGEN introduced therascreen PIK3CA RGQ PCR Kit as a companion diagnostic for Novartis proprietary PIQRAY in guiding treatment decisions from tissue and liquid biopsy.

In January 2019, the Fujifilm Holdings Corporation introduced its Tomosynthesis Biopsy option for ASPIRE Cristalle mammography system. This technique was expected to enable physicians to detect breast cancers more efficiently compared to others by providing an enhanced 3D image and a digital mammogram.

However, there are specific risk factors associated with these imaging procedures. They involve administering high doses of fluorescent and barium contrast agents, as well as radiation exposure in the case of imaging and endoscopic procedures, which can cause several adverse effects such as nausea or diarrhea. The risks of ionizing radiation exposure associated with the use of CT, MRI, and X-rays, as well as the use of radioactive tracer injections in PET can limit the adoption of such screening procedures. Therefore, factors such as adverse effects of imaging act as a challenge for the companies in this market.

Breast Cancer Diagnostics Market Report Highlights:

  • The imaging segment held the largest revenue share in 2024 and the blood tests segment is expected to grow at the fastest rate.
  • By product, the instrument-based products segment accounted for the largest revenue share in 2024 due to government initiatives such as mandatory screening in developed countries such as the U.S., Canada, and the U.K. for women above 45 years of age, increasing the overall testing and screening of breast cancer.
  • The platform-based products segment is expected to witness the fastest growth over the forecast period. These tests are mostly used for assessing the efficacy of chemotherapy and targeted therapy in women.
  • By application, the diagnostic and predictive segment dominated the market in 2024 and the prognostic segment is expected to witness the fastest CAGR over the forecast period due to increasing collaborations and efforts for advancements in diagnostics.
  • The hospitals and clinics segment is expected to demonstrate a steady growth rate of 6.92% due to the rising number of hospitalizations and increasing burden of breast cancer.
  • The medical labs and diagnostics centers segment is expected to witness the fastest CAGR over the forecast period due to an increase in platform-based testing such as NGS, and PCR.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Market Definitions
  • 1.2. Regional Scope
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Type and Product Snapshot
  • 2.3. Application and End Use Snapshot
  • 2.4. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Trends and Outlook
  • 3.3. Market Dynamics
    • 3.3.1. Market Driver Analysis
    • 3.3.2. Market Restraint Analysis
  • 3.4. Business Environment Analysis
    • 3.4.1. PESTLE Analysis
    • 3.4.2. Porter's Five Forces Analysis
  • 3.5. COVID-19 Impact Analysis

Chapter 4. Type Business Analysis

  • 4.1. Breast Cancer Diagnostics Market: Type Movement Analysis, 2024 & 2030
  • 4.2. Imaging
    • 4.2.1. Imaging Market, 2018 - 2030 (USD Million)
  • 4.3. Biopsy
    • 4.3.1. Biopsy Market, 2018 - 2030 (USD Million)
  • 4.4. Genomic Tests
    • 4.4.1. Genomic Tests Market, 2018 - 2030 (USD Million)
  • 4.5. Blood Tests
    • 4.5.1. Blood Tests Market, 2018 - 2030 (USD Million)
  • 4.6. Others
    • 4.6.1. Others Market, 2018 - 2030 (USD Million)

Chapter 5. Product Business Analysis

  • 5.1. Breast Cancer Diagnostics Market: Product Movement Analysis, 2024 & 2030
  • 5.2. Platform-based products
    • 5.2.1. Platform-based Products Market, 2018 - 2030 (USD Million)
  • 5.3. Instrument-based products
    • 5.3.1. Instrument-based Products Market, 2018 - 2030 (USD Million)

Chapter 6. Application Business Analysis

  • 6.1. Breast Cancer Diagnostics Market: Application Movement Analysis, 2024 & 2030
  • 6.2. Screening
    • 6.2.1. Screening Market, 2018 - 2030 (USD Million)
  • 6.3. Diagnostic & Predictive
    • 6.3.1. Diagnostic & Predictive Market, 2018 - 2030 (USD Million)
  • 6.4. Prognostic
    • 6.4.1. Prognostic Market, 2018 - 2030 (USD Million)
  • 6.5. Research
    • 6.5.1. Research Market, 2018 - 2030 (USD Million)

Chapter 7. End Use Business Analysis

  • 7.1. Breast Cancer Diagnostics Market: End Use Movement Analysis, 2024 & 2030
  • 7.2. Hospitals & Clinics
    • 7.2.1. Hospitals & Clinics Market, 2018 - 2030 (USD Million)
  • 7.3. Medical labs & Diagnostics Centers
    • 7.3.1. Medical labs & Diagnostics Centers Market, 2018 - 2030 (USD Million)
  • 7.4. Others
    • 7.4.1. Others Market, 2018 - 2030 (USD Million)

Chapter 8. Regional Business Analysis

  • 8.1. Regional Market Snapshot
  • 8.2. North America
    • 8.2.1. North America Breast Cancer Diagnostics Market, 2018 - 2030 (USD Million)
    • 8.2.2. U.S.
      • 8.2.2.1. U.S. Breast Cancer Diagnostics Market, 2018 - 2030 (USD Million)
      • 8.2.2.2. Key Country Dynamics
      • 8.2.2.3. Regulatory Framework
      • 8.2.2.4. Competitive Scenario
    • 8.2.3. Canada
      • 8.2.3.1. Canada Breast Cancer Diagnostics Market, 2018 - 2030 (USD Million)
      • 8.2.3.2. Key Country Dynamics
      • 8.2.3.3. Regulatory Framework
      • 8.2.3.4. Competitive Scenario
    • 8.2.4. Mexico
      • 8.2.4.1. Mexico Breast Cancer Diagnostics Market, 2018 - 2030 (USD Million)
      • 8.2.4.2. Key Country Dynamics
      • 8.2.4.3. Regulatory Framework
      • 8.2.4.4. Competitive Scenario
  • 8.3. Europe
    • 8.3.1. Europe Breast Cancer Diagnostics Market, 2018 - 2030 (USD Million)
    • 8.3.2. Germany
      • 8.3.2.1. Germany Breast Cancer Diagnostics Market, 2018 - 2030 (USD Million)
      • 8.3.2.2. Key Country Dynamics
      • 8.3.2.3. Regulatory Framework
      • 8.3.2.4. Competitive Scenario
    • 8.3.3. UK
      • 8.3.3.1. UK Breast Cancer Diagnostics Market, 2018 - 2030 (USD Million)
      • 8.3.3.2. Key Country Dynamics
      • 8.3.3.3. Regulatory Framework
      • 8.3.3.4. Competitive Scenario
    • 8.3.4. France
      • 8.3.4.1. France Breast Cancer Diagnostics Market, 2018 - 2030 (USD Million)
      • 8.3.4.2. Key Country Dynamics
      • 8.3.4.3. Regulatory Framework
      • 8.3.4.4. Competitive Scenario
    • 8.3.5. Italy
      • 8.3.5.1. Italy Breast Cancer Diagnostics Market, 2018 - 2030 (USD Million)
      • 8.3.5.2. Key Country Dynamics
      • 8.3.5.3. Regulatory Framework
      • 8.3.5.4. Competitive Scenario
    • 8.3.6. Spain
      • 8.3.6.1. Spain Breast Cancer Diagnostics Market, 2018 - 2030 (USD Million)
      • 8.3.6.2. Key Country Dynamics
      • 8.3.6.3. Regulatory Framework
      • 8.3.6.4. Competitive Scenario
    • 8.3.7. Denmark
      • 8.3.7.1. Denmark Breast Cancer Diagnostics Market, 2018 - 2030 (USD Million)
      • 8.3.7.2. Key Country Dynamics
      • 8.3.7.3. Regulatory Framework
      • 8.3.7.4. Competitive Scenario
    • 8.3.8. Sweden
      • 8.3.8.1. Sweden Breast Cancer Diagnostics Market, 2018 - 2030 (USD Million)
      • 8.3.8.2. Key Country Dynamics
      • 8.3.8.3. Regulatory Framework
      • 8.3.8.4. Competitive Scenario
    • 8.3.9. Norway
      • 8.3.9.1. Norway Breast Cancer Diagnostics Market, 2018 - 2030 (USD Million)
      • 8.3.9.2. Key Country Dynamics
      • 8.3.9.3. Regulatory Framework
      • 8.3.9.4. Competitive Scenario
  • 8.4. Asia Pacific
    • 8.4.1. Asia Pacific Breast Cancer Diagnostics Market, 2018 - 2030 (USD Million)
    • 8.4.2. Japan
      • 8.4.2.1. Japan Breast Cancer Diagnostics Market, 2018 - 2030 (USD Million)
      • 8.4.2.2. Key Country Dynamics
      • 8.4.2.3. Regulatory Framework
      • 8.4.2.4. Competitive Scenario
    • 8.4.3. China
      • 8.4.3.1. China Breast Cancer Diagnostics Market, 2018 - 2030 (USD Million)
      • 8.4.3.2. Key Country Dynamics
      • 8.4.3.3. Regulatory Framework
      • 8.4.3.4. Competitive Scenario
    • 8.4.4. India
      • 8.4.4.1. India Breast Cancer Diagnostics Market, 2018 - 2030 (USD Million)
      • 8.4.4.2. Key Country Dynamics
      • 8.4.4.3. Regulatory Framework
      • 8.4.4.4. Competitive Scenario
    • 8.4.5. South Korea
      • 8.4.5.1. South Korea Breast Cancer Diagnostics Market, 2018 - 2030 (USD Million)
      • 8.4.5.2. Key Country Dynamics
      • 8.4.5.3. Regulatory Framework
      • 8.4.5.4. Competitive Scenario
    • 8.4.6. Australia
      • 8.4.6.1. Australia Breast Cancer Diagnostics Market, 2018 - 2030 (USD Million)
      • 8.4.6.2. Key Country Dynamics
      • 8.4.6.3. Regulatory Framework
      • 8.4.6.4. Competitive Scenario
    • 8.4.7. Thailand
      • 8.4.7.1. Thailand Breast Cancer Diagnostics Market, 2018 - 2030 (USD Million)
      • 8.4.7.2. Key Country Dynamics
      • 8.4.7.3. Regulatory Framework
      • 8.4.7.4. Competitive Scenario
  • 8.5. Latin America
    • 8.5.1. Latin America Breast Cancer Diagnostics Market, 2018 - 2030 (USD Million)
    • 8.5.2. Key Country Dynamics
    • 8.5.3. Regulatory Framework
    • 8.5.4. Competitive Scenario
    • 8.5.5. Brazil
      • 8.5.5.1. Brazil Breast Cancer Diagnostics Market, 2018 - 2030 (USD Million)
      • 8.5.5.2. Key Country Dynamics
      • 8.5.5.3. Regulatory Framework
      • 8.5.5.4. Competitive Scenario
    • 8.5.6. Argentina
      • 8.5.6.1. Argentina Breast Cancer Diagnostics Market, 2018 - 2030 (USD Million)
      • 8.5.6.2. Key Country Dynamics
      • 8.5.6.3. Regulatory Framework
      • 8.5.6.4. Competitive Scenario
  • 8.6. MEA
    • 8.6.1. MEA Breast Cancer Diagnostics Market, 2018 - 2030 (USD Million)
    • 8.6.2. South Africa
      • 8.6.2.1. South Africa Breast Cancer Diagnostics Market, 2018 - 2030 (USD Million)
      • 8.6.2.2. Key Country Dynamics
      • 8.6.2.3. Regulatory Framework
      • 8.6.2.4. Competitive Scenario
    • 8.6.3. Saudi Arabia
      • 8.6.3.1. Saudi Arabia Breast Cancer Diagnostics Market, 2018 - 2030 (USD Million)
      • 8.6.3.2. Key Country Dynamics
      • 8.6.3.3. Regulatory Framework
      • 8.6.3.4. Competitive Scenario
    • 8.6.4. UAE
      • 8.6.4.1. UAE Breast Cancer Diagnostics Market, 2018 - 2030 (USD Million)
      • 8.6.4.2. Key Country Dynamics
      • 8.6.4.3. Regulatory Framework
      • 8.6.4.4. Competitive Scenario
    • 8.6.5. Kuwait
      • 8.6.5.1. Kuwait Breast Cancer Diagnostics Market, 2018 - 2030 (USD Million)
      • 8.6.5.2. Key Country Dynamics
      • 8.6.5.3. Regulatory Framework
      • 8.6.5.4. Competitive Scenario

Chapter 9. Competitive Landscape

  • 9.1. Company Categorization
  • 9.2. Strategy Mapping
    • 9.2.1. Acquisition
    • 9.2.2. Collaborations
    • 9.2.3. New Platform Launches
    • 9.2.4. Others
  • 9.3. Company Profiles/Listing
    • 9.3.1. Hologic Inc.
      • 9.3.1.1. Company Overview
      • 9.3.1.2. Financial Performance
      • 9.3.1.3. Platform Benchmarking
      • 9.3.1.4. Strategic Initiatives
    • 9.3.2. Genomic Health (Exact Sciences Corporation)
      • 9.3.2.1. Company Overview
      • 9.3.2.2. Financial Performance
      • 9.3.2.3. Platform Benchmarking
      • 9.3.2.4. Strategic Initiatives
    • 9.3.3. BD
      • 9.3.3.1. Company Overview
      • 9.3.3.2. Financial Performance
      • 9.3.3.3. Platform Benchmarking
      • 9.3.3.4. Strategic Initiatives
    • 9.3.4. Danaher
      • 9.3.4.1. Company Overview
      • 9.3.4.2. Financial Performance
      • 9.3.4.3. Platform Benchmarking
      • 9.3.4.4. Strategic Initiatives
    • 9.3.5. Koninklijke Philips N.V
      • 9.3.5.1. Company Overview
      • 9.3.5.2. Financial Performance
      • 9.3.5.3. Platform Benchmarking
      • 9.3.5.4. Strategic Initiatives
    • 9.3.6. QIAGEN
      • 9.3.6.1. Company Overview
      • 9.3.6.2. Financial Performance
      • 9.3.6.3. Platform Benchmarking
      • 9.3.6.4. Strategic Initiatives
    • 9.3.7. Thermo Fisher Scientific Inc
      • 9.3.7.1. Company Overview
      • 9.3.7.2. Financial Performance
      • 9.3.7.3. Platform Benchmarking
      • 9.3.7.4. Strategic Initiatives
    • 9.3.8. Myriad Genetics
      • 9.3.8.1. Company Overview
      • 9.3.8.2. Financial Performance
      • 9.3.8.3. Platform Benchmarking
      • 9.3.8.4. Strategic Initiatives
    • 9.3.9. Argon Medical Devices, Inc.
      • 9.3.9.1. Company Overview
      • 9.3.9.2. Financial Performance
      • 9.3.9.3. Platform Benchmarking
      • 9.3.9.4. Strategic Initiatives
    • 9.3.10. F. Hoffmann-La Roche Ltd.
      • 9.3.10.1. Company Overview
      • 9.3.10.2. Financial Performance
      • 9.3.10.3. Platform Benchmarking
      • 9.3.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global Breast Cancer Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 4 Global Breast Cancer Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 5 Global Breast Cancer Diagnostics Market, by Application, 2018 - 2030 (USD Million)
  • Table 6 Global Breast Cancer Diagnostics Market, by End Use, 2018 - 2030 (USD Million)
  • Table 7 Global Breast Cancer Diagnostics Market, by Region, 2018 - 2030 (USD Million)
  • Table 8 North America Breast Cancer Diagnostics Market, by Country, 2018 - 2030 (USD Million)
  • Table 9 North America Breast Cancer Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 10 North America Breast Cancer Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 11 North America Breast Cancer Diagnostics Market by Application, 2018 - 2030 (USD Million)
  • Table 12 North America OTC US Breast Cancer Diagnostics Market, by End Use, 2018 - 2030 (USD Million)
  • Table 13 U.S Breast Cancer Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 14 U.S Breast Cancer Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 15 U.S Breast Cancer Diagnostics Market by Application, 2018 - 2030 (USD Million)
  • Table 16 U.S Breast Cancer Diagnostics Market by End Use, 2018 - 2030 (USD Million)
  • Table 17 Canada Breast Cancer Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 18 Canada Breast Cancer Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 19 Canada Breast Cancer Diagnostics Market by Application, 2018 - 2030 (USD Million)
  • Table 20 Canada Breast Cancer Diagnostics Market by End Use, 2018 - 2030 (USD Million)
  • Table 21 Mexico Breast Cancer Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 22 Mexico Breast Cancer Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 23 Mexico Breast Cancer Diagnostics Market by Application, 2018 - 2030 (USD Million)
  • Table 24 Mexico Breast Cancer Diagnostics Market by End Use, 2018 - 2030 (USD Million)
  • Table 25 Europe Breast Cancer Diagnostics Market, by Country, 2018 - 2030 (USD Million)
  • Table 26 Europe Breast Cancer Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 27 Europe Breast Cancer Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 28 Europe Breast Cancer Diagnostics Market by Application, 2018 - 2030 (USD Million)
  • Table 29 Europe Breast Cancer Diagnostics Market by End Use, 2018 - 2030 (USD Million)
  • Table 30 UK Breast Cancer Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 31 UK Breast Cancer Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 32 UK Breast Cancer Diagnostics Market by Application, 2018 - 2030 (USD Million)
  • Table 33 UK Breast Cancer Diagnostics Market by End Use, 2018 - 2030 (USD Million)
  • Table 34 Germany Breast Cancer Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 35 Germany Breast Cancer Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 36 Germany Breast Cancer Diagnostics Market by Application, 2018 - 2030 (USD Million)
  • Table 37 Germany Breast Cancer Diagnostics Market by End Use, 2018 - 2030 (USD Million)
  • Table 38 France Breast Cancer Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 39 France Breast Cancer Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 40 France Breast Cancer Diagnostics Market by Application, 2018 - 2030 (USD Million)
  • Table 41 France Breast Cancer Diagnostics Market by End Use, 2018 - 2030 (USD Million)
  • Table 42 Italy Breast Cancer Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 43 Italy Breast Cancer Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 44 Italy Breast Cancer Diagnostics Market by Application, 2018 - 2030 (USD Million)
  • Table 45 Italy Breast Cancer Diagnostics Market by End Use, 2018 - 2030 (USD Million)
  • Table 46 Spain Breast Cancer Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 47 Spain Breast Cancer Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 48 Spain Breast Cancer Diagnostics Market by Application, 2018 - 2030 (USD Million)
  • Table 49 Spain Breast Cancer Diagnostics Market by End Use, 2018 - 2030 (USD Million)
  • Table 50 Norway Breast Cancer Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 51 Norway Breast Cancer Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 52 Norway Breast Cancer Diagnostics Market by Application, 2018 - 2030 (USD Million)
  • Table 53 Norway Breast Cancer Diagnostics Market by End Use, 2018 - 2030 (USD Million)
  • Table 54 Sweden Breast Cancer Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 55 Sweden Breast Cancer Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 56 Sweden Breast Cancer Diagnostics Market by Application, 2018 - 2030 (USD Million)
  • Table 57 Sweden Breast Cancer Diagnostics Market by End Use, 2018 - 2030 (USD Million)
  • Table 58 Denmark Breast Cancer Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 59 Denmark Breast Cancer Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 60 Denmark Breast Cancer Diagnostics Market by Application, 2018 - 2030 (USD Million)
  • Table 61 Denmark Breast Cancer Diagnostics Market by End Use, 2018 - 2030 (USD Million)
  • Table 62 Asia Pacific Breast Cancer Diagnostics Market, by Country, 2018 - 2030 (USD Million)
  • Table 63 Asia Pacific Breast Cancer Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 64 Asia Pacific Breast Cancer Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 65 Asia Pacific Breast Cancer Diagnostics Market by Application, 2018 - 2030 (USD Million)
  • Table 66 Asia Pacific Breast Cancer Diagnostics Market by End Use, 2018 - 2030 (USD Million)
  • Table 67 Japan Breast Cancer Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 68 Japan Breast Cancer Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 69 Japan Breast Cancer Diagnostics Market by Application, 2018 - 2030 (USD Million)
  • Table 70 Japan Breast Cancer Diagnostics Market by End Use, 2018 - 2030 (USD Million)
  • Table 71 China Breast Cancer Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 72 China Breast Cancer Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 73 China Breast Cancer Diagnostics Market by Application, 2018 - 2030 (USD Million)
  • Table 74 China Breast Cancer Diagnostics Market by End Use, 2018 - 2030 (USD Million)
  • Table 75 India Breast Cancer Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 76 India Breast Cancer Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 77 India Breast Cancer Diagnostics Market by Application, 2018 - 2030 (USD Million)
  • Table 78 India Breast Cancer Diagnostics Market by End Use, 2018 - 2030 (USD Million)
  • Table 79 Australia Breast Cancer Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 80 Australia Breast Cancer Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 81 Australia Breast Cancer Diagnostics Market by Application, 2018 - 2030 (USD Million)
  • Table 82 Australia Breast Cancer Diagnostics Market by End Use, 2018 - 2030 (USD Million)
  • Table 83 South Korea Breast Cancer Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 84 South Korea Breast Cancer Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 85 South Korea Breast Cancer Diagnostics Market by Application, 2018 - 2030 (USD Million)
  • Table 86 South Korea Breast Cancer Diagnostics Market by End Use, 2018 - 2030 (USD Million)
  • Table 87 Thailand Breast Cancer Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 88 Thailand Breast Cancer Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 89 Thailand Breast Cancer Diagnostics Market by Application, 2018 - 2030 (USD Million)
  • Table 90 Thailand Breast Cancer Diagnostics Market by End Use, 2018 - 2030 (USD Million)
  • Table 91 Latin America Breast Cancer Diagnostics Market, by Country, 2018 - 2030 (USD Million)
  • Table 92 Latin America Breast Cancer Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 93 Latin America Breast Cancer Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 94 Latin America Breast Cancer Diagnostics Market by Application, 2018 - 2030 (USD Million)
  • Table 95 Latin America Breast Cancer Diagnostics Market by End Use, 2018 - 2030 (USD Million)
  • Table 96 Brazil Breast Cancer Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 97 Brazil Breast Cancer Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 98 Brazil Breast Cancer Diagnostics Market by Application, 2018 - 2030 (USD Million)
  • Table 99 Brazil Breast Cancer Diagnostics Market by End Use, 2018 - 2030 (USD Million)
  • Table 100 Argentina Breast Cancer Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 101 Argentina Breast Cancer Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 102 Argentina Breast Cancer Diagnostics Market by Application, 2018 - 2030 (USD Million)
  • Table 103 Argentina Breast Cancer Diagnostics Market by End Use, 2018 - 2030 (USD Million)
  • Table 104 Middle East Africa Breast Cancer Diagnostics Market, by Country, 2018 - 2030 (USD Million)
  • Table 105 Middle East Africa Breast Cancer Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 106 Middle East Africa Breast Cancer Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 107 Middle East Africa Breast Cancer Diagnostics Market by Application, 2018 - 2030 (USD Million)
  • Table 108 Middle East Africa Breast Cancer Diagnostics Market by End Use, 2018 - 2030 (USD Million)
  • Table 109 South Africa Breast Cancer Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 110 South Africa Breast Cancer Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 111 South Africa Breast Cancer Diagnostics Market by Application, 2018 - 2030 (USD Million)
  • Table 112 South Africa Breast Cancer Diagnostics Market by End Use, 2018 - 2030 (USD Million)
  • Table 113 Saudi Arabia Breast Cancer Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 114 Saudi Arabia Breast Cancer Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 115 Saudi Arabia Breast Cancer Diagnostics Market by Application, 2018 - 2030 (USD Million)
  • Table 116 Saudi Arabia Breast Cancer Diagnostics Market by End Use, 2018 - 2030 (USD Million)
  • Table 117 UAE Breast Cancer Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 118 UAE Breast Cancer Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 119 UAE Breast Cancer Diagnostics Market by Application, 2018 - 2030 (USD Million)
  • Table 120 UAE Breast Cancer Diagnostics Market by End Use, 2018 - 2030 (USD Million)
  • Table 121 Kuwait Breast Cancer Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 122 Kuwait Breast Cancer Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 123 Kuwait Breast Cancer Diagnostics Market by Application, 2018 - 2030 (USD Million)
  • Table 124 Kuwait Breast Cancer Diagnostics Market by End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market Research Process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 Market Segmentation
  • Fig. 8 Market Snapshot, 2024
  • Fig. 9 Market Trends & Outlook
  • Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 12 SWOT Analysis, By Factor (Political & Legal, Economic, And Technological)
  • Fig. 13 Porter's Five Forces Analysis
  • Fig. 14 Market Penetration & Growth Prospect Mapping, 2024
  • Fig. 15 Global Breast Cancer Diagnostics Market: Type Movement Analysis
  • Fig. 16 Global Imaging Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 17 Global Biopsy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 18 Global Genomic Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 19 Global Blood Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Global Other Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Global Breast Cancer Diagnostics Market: Product Movement Analysis
  • Fig. 22 Global Platform-Based Products Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Global Imaging Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Global Biopsy Products Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Global Instrument-Based Products Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Global Microarrays Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Global PCR Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Global Next Generation Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Global Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Global Breast Cancer Diagnostics Market: Application Movement Analysis
  • Fig. 31 Global Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Global Diagnostic & Predictive Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Global Prognostic Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Global Research Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Global Breast Cancer Diagnostics Market: End Use Movement Analysis
  • Fig. 36 Global Hospitals & Clinics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Global Medical Labs & Diagnostics Centres Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Global Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Regional Marketplace: Key Takeaways
  • Fig. 40 Regional Outlook, 2024 & 2030
  • Fig. 41 Global Breast Cancer Diagnostics Market: Regional Movement Analysis
  • Fig. 42 North America Breast Cancer Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 U.S. Breast Cancer Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Canada Breast Cancer Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Mexico Breast Cancer Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Europe Breast Cancer Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Germany Breast Cancer Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 UK Breast Cancer Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 France Breast Cancer Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Italy Breast Cancer Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Spain Breast Cancer Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Denmark Breast Cancer Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Sweden Breast Cancer Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Norway Breast Cancer Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Asia Pacific Breast Cancer Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Japan Breast Cancer Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 China Breast Cancer Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 India Breast Cancer Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Australia Breast Cancer Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 South Korea Breast Cancer Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Thailand Breast Cancer Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Latin America Breast Cancer Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Brazil Breast Cancer Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Argentina Breast Cancer Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Middle East And Africa Breast Cancer Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 South Africa Breast Cancer Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Saudi Arabia Breast Cancer Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 UAE Breast Cancer Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 Kuwait Breast Cancer Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)